32 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
of Elicio’s Business—Government Regulation and Product Approval—FDA Regulation—Fraud and Abuse, Data Privacy and Security, and Transparency Laws … accounting provisions.
Elicio is subject to stringent privacy laws, information security laws, regulations, policies and contractual obligations related
8-K
EX-99.3
wciile4 s2b9q2uw
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
im168k50r a1
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
5oe5l2l 3a
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.26
9lar8sllgksc6
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.27
rgcv1x
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.28
pk3i4b
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
10-Q
y1ykhyw 4f89a1aj
17 May 21
Quarterly report
6:03am